1998
DOI: 10.1016/s0015-0282(98)00022-3
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
143
0
12

Year Published

2005
2005
2020
2020

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 253 publications
(157 citation statements)
references
References 5 publications
2
143
0
12
Order By: Relevance
“…One study, using the Japanese quail, has shown that administration of an aromatase antagonist can reverse gonadectomyinduced decreases in the nociceptive threshold (Evrard and Balthazart, 2003). Furthermore, aromatase inhibitors have shown promise in the treatment of pelvic pain associated with endometriosis (Takayama et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…One study, using the Japanese quail, has shown that administration of an aromatase antagonist can reverse gonadectomyinduced decreases in the nociceptive threshold (Evrard and Balthazart, 2003). Furthermore, aromatase inhibitors have shown promise in the treatment of pelvic pain associated with endometriosis (Takayama et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…12 Previous studies demonstrated that transvaginal ultrasonography was able to assess the mass in the pelvic and to distinguish between ovarian endometriosis and other ovarian masses. 10 Transvaginal ultrasonography has a sensitivity of 84% and specificity of 90% in the ovarian mass. 12 In this study, 32 cases were diagnosed with adenomyosis using transvaginal USG.…”
Section: Discussionmentioning
confidence: 99%
“…Sonuç olarak, aromataz inhibitörlerinin endometriyozis tedavisinde etkili bir seçim olabileceği beyan edilmiştir. 9 Ferroro ve ark.nın 2013 yılında yayımlanan ça-lışmasında, laparoskopik veya laparotomik olarak derin endometriyozisi eksize edilemeyen ve histopatolojik tanı almış, postoperatif ağrısı olan 35 premenopozal kadına günde 2,5 mg letrazol, 1000 mg kalsiyum, 880 IU vitamin D3 (calcit vitamina D3) verilmiştir. Bu hastaların 18'ine üç ayda bir intramusküler depo triptorelin (11,25 decapeptyl), 17'sine de oral norethisterone asetat (2,5 mg/gün primolutnor), altı ay boyunca ilave olarak verilerek, dismenore, nonmenstrüel ağrı ve derin disparoninin şiddeti tedavi süresince vizüel analog skala (VAS) skorlaması ile değerlendirilmiştir.…”
Section: Aromataz İnhi̇bi̇törleri̇unclassified